Article 1 to 9 out of 9 concerning Oxford Gene Technology (OGT)
Oxford Gene Technology joins EuroSyStem Consortium(05/26/2008) Oxford Gene Technology (OGT) announced its participation in the recently formed EuroSyStem Consortium, a framework V11 partnership which aims to drive the generation of new knowledge about the characteristics of normal and abnormal stem cells. The ...
Oxford Gene Technology appointed Agilent Certified Service Provider (CSP) in Europe(03/12/2008) Oxford Gene Technology (OGT) and Agilent Technologies, Inc. announced OGT's officially granted status as an Agilent microarray Certified Service Provider (CSP) in Europe following the completion of several successful projects. To date, OGT has been ...
How Salmonella avoid getting sick after DNA transfer(08/22/2006) Scientists at the Institute of Food Research in Norwich revealed how the promiscuous Salmonella bacterium protects itself from getting ill after acquiring foreign DNA through "sex" with other bacteria. This discovery could lead to the design of new ...
Oxford Gene Technology grants microarray license to Japanese life science companies(08/21/2006) Oxford Gene Technology (OGT) announced the conclusion of a series of Japanese licensing agreements giving Bio Matrix Research Inc. and Filgen Inc. access to OGT's "Southern array patents", the fundamental patents covering the manufacture and ...
Oxford Gene Technology grants microarray license to NGK Insulators Ltd.(08/04/2006) Oxford Gene Technology (OGT) announced the conclusion of a Japanese licensing agreement giving NGK Insulators Ltd. access to OGT's "Southern array patents", the fundamental patents covering the manufacture and marketing of oligonucleotide ...
Oxford Gene Technology and Applied InSilico Ltd announce development agreement(11/21/2005) Oxford Gene Technology (OGT) and Applied InSilico (AI) announced a development agreement whereby AI will provide computational analysis services to OGT. AI will use its ELE(tm) (Evolutionary Learning Environment) software platform to analyse data ...
Oxford Gene Technology appoints Dr David Owen to the Board(10/06/2005) Oxford Gene Technology (OGT) announced the appointment of Dr David Owen to the OGT Board as a Non-Executive Director.After graduating with a PhD in pharmacology, David worked in R&D in the pharmaceutical industry for 20 years (Sandoz and SmithKline ...
Oxford Gene Technology grants microarray licence to the Norwegian Microarray Consortium(09/05/2005) Oxford Gene Technology (OGT) granted a microarray licence to the Norwegian Microarray Consortium (NMC). The NMC provides spotted DNA microarray technology and related services to the scientific community in Norway. This licence allows the NMC to ...
Oxford Gene Technology and Schott Nexterion sign partnership agreement(08/26/2005) Oxford Gene Technology (OGT), a pioneer in the development of molecular tools for biologists has signed a partnership agreement with Schott Nexterion to serve as a reference site for its glass substrates for oligonucleotide microarraying.Schott ...